Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer

M Marín-Aguilera, J Codony-Servat, Ò Reig… - Molecular cancer …, 2014 - AACR
Molecular characterization of radical prostatectomy specimens after systemic therapy may
identify a gene expression profile for resistance to therapy. This study assessed tumor cells …
被引用次数：171 相关文章
[PDF] archive.org

[PDF][PDF] Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer

M Marín-Aguilera, J Codony-Servat, O Reig… - Mol Cancer …, 2014 - scholar.archive.org
Molecular characterization of radical prostatectomy specimens after systemic therapy may
identify a gene expression profile for resistance to therapy. This study assessed tumor cells …

Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer

M Marín Aguilera, J Codony Servat, O Reig… - … , 2014, vol. 13, num. 5 …, 2014 - diposit.ub.edu
Molecular characterization of radical prostatectomy specimens after systemic therapy may
identify a gene expression profile for resistance to therapy. This study assessed tumor cells …

Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer

M Marín-Aguilera, J Codony-Servat, Ò Reig… - Molecular Cancer …, 2014 - cir.nii.ac.jp
< jats: title> Abstract</jats: title>< jats: p> Molecular characterization of radical prostatectomy
specimens after systemic therapy may identify a gene expression profile for resistance to …

Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer.

M Marín-Aguilera, J Codony-Servat, Ò Reig… - Molecular Cancer …, 2014 - europepmc.org
Molecular characterization of radical prostatectomy specimens after systemic therapy may
identify a gene expression profile for resistance to therapy. This study assessed tumor cells …

Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer

M Marin-Aguilera, J Codony-Servat… - Molecular Cancer …, 2014 - portalrecerca.uab.cat
Molecular characterization of radical prostatectomy specimens after systemic therapy may
identify a gene expression profile for resistance to therapy. This study assessed tumor cells …
[PDF] researchgate.net

[PDF][PDF] Epithelial-to-Mesenchymal Transition Mediates Docetaxel

M Marín-Aguilera, J Codony-Servat, Ò Reig - Mol Cancer Ther, 2014 - researchgate.net
Molecular characterization of radical prostatectomy specimens after systemic therapy may
identify a gene expression profile for resistance to therapy. This study assessed tumor cells …

Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer

M Marín-Aguilera, J Codony-Servat… - Molecular cancer …, 2014 - pubmed.ncbi.nlm.nih.gov
Molecular characterization of radical prostatectomy specimens after systemic therapy may
identify a gene expression profile for resistance to therapy. This study assessed tumor cells …
[PDF] psu.edu

[PDF][PDF] Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer

M Marín-Aguilera, J Codony-Servat, O Reig, JJ Lozano… - Mol Cancer Ther, 2014 - Citeseer
Molecular characterization of radical prostatectomy specimens after systemic therapy may
identify a gene expression profile for resistance to therapy. This study assessed tumor cells …

Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer

M Marin-Aguilera, J Codony-Servat, O Reig, JJ Lozano… - 2014 - recercat.cat
Molecular characterization of radical prostatectomy specimens after systemic therapy may
identify a gene expression profile for resistance to therapy. This study assessed tumor cells …